{"brief_title": "A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)", "brief_summary": "This is a Phase IIIb, multicenter, open-label trial of daily oral Tarceva in patients with advanced (inoperable Stage IIIb or IV) NSCLC who have progressed following standard chemotherapy treatment.", "condition": "Non-small-cell Lung Carcinoma", "intervention_type": "Drug", "intervention_name": "Tarceva (erlotinib HCl)", "criteria": "Inclusion Criteria: - Written (signed) informed consent(s) - Inoperable and incurable, locally advanced, recurrent or metastatic NSCLC - Relapse following standard chemotherapy (combination chemotherapy such as two-drug combination chemotherapy, or a single-agent chemotherapy agent for elderly or poor performance status patients) - Age >=18 years - ECOG performance status of 0 to 3 - Recovered from the toxic effects of prior therapy - Able to comply with study and follow-up procedures - Able to take oral medication - Use of an effective means of contraception (for patients with reproductive potential) - Granulocyte count >=1.0 x 10^9/L - Platelet count >=75 x 10^9/L - Serum bilirubin <1.5 x upper limit of normal (ULN) - SGOT (AST) <2 x ULN unless elevation is clearly due to liver metastases; then SGOT (AST) must be <5 x ULN - Serum creatinine <=1.5 mg/dL Exclusion Criteria: - Any unstable systemic disease (including active infection, unstable angina, congestive heart failure, myocardial infarction within the last 6 months, hepatic, renal, or metabolic disease) - Prior therapy with any systemic HER1/EGFR small molecule inhibitor, including gefitinib (Iressa), erlotinib (Tarceva), or other investigational agents in this class - History of another malignancy in the past 2 years unless the malignancy has been adequately treated and is associated with a 5-year anticipated survival of >=90% - Known central nervous system (CNS) metastases that have not yet been definitively treated with surgery and/or radiation or that are symptomatic or unstable - Nursing mothers or pregnant females", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00091663.xml"}